The primary goal of this Pain Management Market report is to maintain the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the Pain Management market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the market. The impact of prevailing regulatory scenario on both regional and worldwide Pain Management market is provided in detail in the report.

Get Sample Copy of Pain Management Market Report @

Key Market Trends:

Cancer Pain Segment is Expected to Exhibit the Fastest Growth Rate over the Forecast Period

Pain during cancer occurs the most when a tumor presses on to the bones, nerves, or organs. The pain may vary according to the affected location. Chemotherapy, radiotherapy, and surgery can also cause pain. Certain painful conditions are likely to occur more in patients with a suppressed immune system, which is often a result of these therapies.

Pain caused by cancer can be treated. About nine out of ten cancer patients suffering from pain find relief by using a combination of medications. Many medicines are used for pain management in cancer patients. Some drugs are general pain relievers, while other target specific types of pain may require a prescription. The increasing incidences of various forms of cancer are likely to directly lead to an increase in cancer pain cases, the treatment of which, both through drugs and devices, is expected to contribute to the market growth.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America holds the largest share in the pain management market, with the United States being the largest contributor to its revenue. According to the data published by the Centers for Disease Control and Prevention (CDC), in 2016, approximately 20.4% of adults in the United States (which is about 50.0 million) were suffering from chronic pain and 8.0% of adults in the country (which is about 19.6 million) were suffering from high-impact chronic pain, with higher prevalence associated with advancing age. Overall, pain management in the United States is considered to be the most developed in the world, primarily due to the large presence of pain specialist physicians, increasing number of approvals from FDA, and the robust infrastructure for providing pain management services to patients.

Pain Management Market Covers Key Players:

  • Abbott Laboratories
  • AstraZeneca
  • Baxter International Inc.
  • Becton Dickinson & Company
  • Boston Scientific Corporation
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Medtronic PLC
  • Novartis AG
  • Pfizer
  • Teva Pharmaceutical Industries Ltd

    Ask for Discount at

    Geographical Landscape:

    This Report Focuses on the Pain Management in the market, especially in North America, China, Europe, Japan, Southeast Asia, India. This report categorizes the market based on manufacturers, regions, type, and application

    Market Overview:

  • The growth of the pain management drugs and devices market is majorly due to the well-established business of painkiller medications as the first line of treatment. In recent years, the increasing reliance on their prolonged use and a greater understanding of their side-effects have led to the growing use of device-based pain management therapies. Presently, at the country level, economic factors play a significant role in the management of financial implications for hospitals. Postsurgical pain is one of the primary focuses of hospitals, where the cost of monitoring and the treatment of adverse effects creates the major demand for pain management drugs and devices.
  • The current market is gradually adopting more non-opioid medications to suppress the addiction toward opioids and certain well-established painkillers in the market. There are several non-opioid drugs with mechanisms of action that are currently in early and late-stage development. The federal authorities in multiple countries are shifting to alternative approaches, and thus, fast-tracking those drugs to market approval. The shift is expected to be gradual, and thus pain management has very attractive growth prospects between 2019 and 2024.

    Report Highlights:

    – The report provides a detailed analysis on current and future market trends to identify the investment opportunities

    – Market forecasts till 2024, using estimated market values as the base numbers

    – Key market trends across the business segments, Regions and Countries

    – Key developments and strategies observed in the market

    – Market Dynamics such as Drivers, Restraints, Opportunities and other trends

    – In-depth company profiles of key players and upcoming prominent players

    – Growth prospects among the emerging nations through 2024

    – Pain Management Market opportunities and recommendations for new investments

    Price Of Report: $ 4250 (SUL)

    Purchase Pain Management Market Report @

    Detailed TOC of Pain Management Market Research Report 2019 – 2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Demand for Long-term Pain Management from the Geriatric Population
    4.2.2 High Proven Efficacy of Pain Management Devices for the Treatment of Chronic Pain
    4.2.3 Rise in Acute and Chronic Pain as a Result of Chronic Health Conditions
    4.2.4 Development of Novel Pain Management Devices
    4.3 Market Restraints
    4.3.1 Lack of Awareness about the Availability and Use of Pain Management Devices
    4.3.2 Shortage of Pain Specialists and the Low Number of Pain Clinics in Several Countries
    4.3.3 High Procedural and Purchase Cost of Pain Management Devices
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Mode of Pain Management
    5.1.1 Drugs Opioids Non-narcotic Analgesics NSAIDS Anesthetics Anticonvulsants Anti-depressants Other Non-narcotic Analgesics
    5.1.2 Devices Neurostimulation Devices Transcutaneous Electrical Nerve Stimulation (TENS) Devices Brain and Spinal Cord Stimulation (SCS) Devices Analgesic Infusion Pumps Intrathecal Infusion Pumps External Infusion Pumps
    5.2 By Application
    5.2.1 Neuropathic Pain
    5.2.2 Cancer Pain
    5.2.3 Facial Pain and Migraine
    5.2.4 Musculoskeletal Pain
    5.2.5 Other Applications
    5.3 Geography
    5.3.1 North America United States Canada Mexico
    5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Abbott Laboratories
    6.1.2 AstraZeneca
    6.1.3 Baxter International Inc.
    6.1.4 Becton Dickinson & Company
    6.1.5 Boston Scientific Corporation
    6.1.6 Fresenius SE & Co. KGaA
    6.1.7 GlaxoSmithKline PLC
    6.1.8 Johnson & Johnson
    6.1.9 Medtronic PLC
    6.1.10 Novartis AG
    6.1.11 Pfizer
    6.1.12 Teva Pharmaceutical Industries Ltd


    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: [email protected]

    Our latest Report: Gamma Oryzanol Market Report Upstream and Downstream Analysis by Production and Consumption, Forecast to 2025

  • Avatar
    News Reporter